Lisata Therapeutics (NASDAQ:LSTA) reported quarterly losses of $(7.88) per share. This is a 352.87 percent decrease over losses of $(1.74) per share from the same period last year.
Evercore ISI Group Maintains Outperform on Macy’s, Lowers Price Target to $30
Evercore ISI Group analyst Omar Saad maintains Macy's (NYSE:M) with a Outperform and lowers the price target from $35 to $30.